Medical Disorders in Pregnancy - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Medical Disorders in Pregnancy

Description:

Medical Disorders in Pregnancy Dr Than Than Yin Obstetric cholestasis Unique to pregnancy Severe pruritus affecting limbs and trunk mainly palm and sole Developing in ... – PowerPoint PPT presentation

Number of Views:1710
Avg rating:3.0/5.0
Slides: 21
Provided by: mls2
Category:

less

Transcript and Presenter's Notes

Title: Medical Disorders in Pregnancy


1
Medical Disorders in Pregnancy
  • Dr Than Than Yin

2
Obstetric cholestasis
  • Unique to pregnancy
  • Severe pruritus affecting limbs and trunk mainly
    palm and sole
  • Developing in the second half of pregnancy
    (usually during the third trimester)

3
Diagnosis
  • A typical history of pruritus without rash
  • Abnormal liver function tests
  • Moderate lt less than three-fold elevation in
    transamimases ( ALT is the most sensitive)
  • Raised ALP 9gt pregnancy values
  • Raised ? glutamyl transpeptidase
  • Mild elevation of bilirubin
  • Increased total serum bile acid
  • Exclusion of other causes of itching and abnormal
    liver function

4
Diagnosis
  • To exclude other causes of abnormal liver
    function
  • Liver scan
  • Viral serology ( for hepatitis A,B,C and E,EBV
    and CMV)
  • Liver autoantibodies( for pre-exisisting liver
    diseasse, anti-smooth muscle antibodies,
    antimitochondrial antibodies

5
Management
  • Counselling
  • Weekly LFT and bile acids
  • No evidence of monitoring fetal well-being
  • To check prothrombin time prior to delivery

6
Intrapartum management
  • Labour may be induced at 37-38 weeks gestation if
    persistantly raised bile acid levels
  • If bile acid levels lt 40 µmol/L, reasonable to
    await spontaneous onset of labour

7
Drug therapy
  • Vitamin K mandatoroy for women with prolonged
    prothrombin time, commenced at 32 weeks
  • Antihistamine
  • Ursodeoxycholic acid
  • Dexamethasone
  • Rifampicin
  • Cholestyramine
  • S-Adenosylmethionine
  • Activated charcol
  • Epomediol

8
Diagnosis
  • BP, urinalysis, uric acid, platelet count,
    clotting screen, blood film
  • Blood glucose, serum calcium, sodium, liver
    function tests
  • CT or MRI
  • EEG

9
Epilepsy in pregnancy
  • Many cases are idiopathic
  • 30 have a family history of epilepsy
  • Secondary Epilepsy
  • Previous surgery
  • Intracranial mass or lesions
  • Antiphospholipid syndrome

10
Effect of pregnancy on epilepsy
  • A common indirect maternal death
  • No effect in majority
  • Women who have been seizure free for years are
    unlikely to have seizures in pregnancy
  • Women with multiple type seizures are more
    likely to have increase in seizure frequency
  • The risk of seizures is highest in peripartum
  • Sudden Unexplained Death in Pregnancy (SUDEP)-
    risk factors
  • seizure frequency
  • Increasing number of antiepileptic drugs
  • Low IQ
  • Early onset epilepsy

11
Effect of epilepsy on pregnancy
  • The fetus is relatively resistant to short
    periods of hypoxia
  • No increased risk of miscarriage or obstetric
    complications
  • Status epilepticus is dangerous for both mother
    and fetus
  • The risk of child developing epilepsy is
    increased (4-5) if either parent has epilepsy
    and, risk is 10-15 if both parents have
    epilepsy, 10 risk with previously effected
    sibling

12
Teratogenic risk of anti-epileptic drugs(AED)
  • Phenytoin, primidone, phenobarbitone,
    carbamazepine, sodium valproate, lamotrigine,
    topiramate and levetiracetam all cross the
    placenta and are teratogenic
  • Major malformations caused by AEDs
  • Neural tube defects ( especially valproates
    1-3.8 and carbamazepine 0.5-1)
  • Orofacial clefts ( particularly Phenytoin,
    carbamazepine, phenobarbitone and valproate)
  • Congenital heart defects (particularly Phenytoin,
    phenobarbitone and valproate)
  • Minor malformations
  • Dysmorphic features
  • Hypertelorism
  • Hypoplastic nails and distal digits
  • Hypoplasia of the mid face

13
Teratogenic risk of anti-epileptic drugs(AED)
  • Metaanalysis of all studies showed that the risk
    of any one drug is approximately 6-7
  • Various theories
  • Genetic deficiency of the detoxifying enzyme
    epoxide hydrolase
  • Cytotxic free radicals
  • Folic acid deficiency

14
Management
  • Antenatal management
  • Folic acid 5mg daily
  • No need to change the AED if epilepsy is well
    controlled
  • Pre-natal screening for congenital abnormalities
    and detailed ultrasound at 18-20 weeks should be
    ordered, including fetal cardiac assessment
  • Vitamin A 10-20mg daily should be prescribed in
    the last four weeks of pregnancy
  • Intrapartum management
  • Risk of seizures increase around the time of
    delivery
  • 1-2 will have a seizure during labour and 1-2
    will have a seizure in post partum 24 hours
    period
  • Should continue regular AED
  • Effective pain relief and epidural analgesia
  • Postnatal management
  • The neonate should recieve 1mg Vitamin K Inj IM
  • Breast feeding should be encouraged

15
Cardiac disease in pregnancy
  • Leading cause of maternal death as result of
  • Myocardial infarction
  • Ischemic heart disease
  • Dissecting aortic aneurism
  • Other heart disease
  • Peripartum cardiomyopathy
  • Rheumatic heart disease- 25 of pregnant
    population who not born in the UK
  • Congenital heart disease

16
Management
  • Preconception counselling
  • Antepartum
  • Risk assessment
  • Joint clinic attended by obstetrician,
    cardiologist, anaesthetist
  • Echocardiogram
  • Fetal echocardiogram for women with congenital
    cardiac disease
  • 32-34 weeks gestation multidisciplinary meeting
    for birth plan
  • Intrapartum
  • Early slow incremental epidural analgesia,
    assisted vaginal delivery
  • Caesarean section is only necessary for obstetric
    indications
  • Postpartum
  • Anticoagulation
  • Long observation in high dependency area
  • Prophylaxis against postpartum haemorrhage
  • Low dose oxytocin infusion

17
Thyroid disease in pregnancy
  • Hyperthyroidism
  • Hyperthyroidism
  • Thyrotoxicosis complicates in 1 in 500
    pregnancies
  • 50 of affected women have a positive family
    history of autoimmune thyroid disease
  • 95 are due to Graves disease, an autoimmune
    disorder caused by TSH receptor stimulating
    antibodies
  • 1 of pregnancies
  • Most cases have already been diagnosed
  • Associated with autoimmune diseases, pernicious
    anemia, vitiligo, type 1 diabetes
  • Commonest causes encountered in pregnancy-
    Hashimotos thyroiditis, treated Graves disease

18
Pregnancy specific normal ranges
TSH(MU/l) Throxine (pmol/L) Triiodothyronine (pmol/L)
Non-pregnant 0.27-4.2 12-22 3.1-6.8
1st trimester 0-5.5 10-16 3-7
2nd trimester 0.5-3.5 9-15.5 3-5.5
3rdt trimester 0.5-4 8-14.5 2-5.5
19
(No Transcript)
20
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com